Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

✍ Scribed by Rosiñol, Laura (author);Oriol, Albert (author);Teruel, Ana Isabel (author);Hernández, Dolores (author);López-Jiménez, Javier (author);De La Rubia, Javier (author);Granell, Miquel (author);Besalduch, Joan (author);Palomera, Luis (author);González, Yolanda (author);Etxebeste, Ma Asunción (author);Díaz-Mediavilla, Joaquín (author);Hernández, Miguel T. (author);De Arriba, Felipe (author);Gutiérrez, Norma C. (author);Martín-Ramos, Ma Luisa (author);Cibeira, Ma Teresa (author);Mateos, Ma Victoria (author);Martínez, Joaquín (author);Alegre, Adrián (author);Lahuerta, Juan José (author);San Miguel, Jesús (author);Bladé, Joan (author)

• Book ID: 118734807
• Publisher: American Society of Hematology
• Year: 2012
• Tongue: English
• Weight: 312 KB
• Volume: 120
• Category: Article
• ISSN: 0006-4971
• DOI: 10.1182/blood-2012-02-408922